ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Diagnostic Nuclear Drug Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-35L5653
Home | Market Reports | Health| Pharmacy
Global Diagnostic Nuclear Drug Market Size Status and Forecast 2021 2027
BUY CHAPTERS

Global Diagnostic Nuclear Drug Market Research Report 2025

Code: QYRE-Auto-35L5653
Report
July 2025
Pages:85
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Bracco Imaging
Lantheus
GE Healthcare
China Isotope & Radiation
Jubilant Pharma
Eli Lilly
Novartis
Siemens AG
Dongcheng
Cardinal Health
Curium Pharma

Diagnostic Nuclear Drug Market Size

The global market for Diagnostic Nuclear Drug was valued at US$ 5363 million in the year 2024 and is projected to reach a revised size of US$ 8500 million by 2031, growing at a CAGR of 6.9% during the forecast period.

Diagnostic Nuclear Drug Market

Diagnostic Nuclear Drug Market

Nuclear Drugs are radioisotopes bound to biological molecules able to target specific organs, tissues or cells within the human body. These radioactive drugs can be used for the diagnosis
The diagnostic radioisotopes market is driven by the increasing prevalence of cancer and cardiovascular diseases, which require advanced imaging techniques for accurate diagnosis and treatment planning. Diagnostic radioisotopes are radioactive compounds used in nuclear medicine imaging to visualize and evaluate physiological processes and detect specific diseases in the body. The rise in the aging population and the need for early and precise diagnosis contribute to market growth. Moreover, advancements in radiopharmaceutical research and the development of new radioisotopes have improved the sensitivity and specificity of diagnostic imaging. However, the market also faces challenges, including the high cost of production and limited availability of some radioisotopes. Additionally, ensuring regulatory compliance and addressing concerns regarding radiation safety can pose obstacles for manufacturers and healthcare facilities. To succeed, companies must focus on research and development to offer innovative and diverse diagnostic radioisotopes, collaborate with healthcare providers to improve nuclear medicine imaging capabilities, and address the challenges to meet the increasing demand for effective and safe diagnostic imaging solutions.
This report aims to provide a comprehensive presentation of the global market for Diagnostic Nuclear Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Diagnostic Nuclear Drug.
The Diagnostic Nuclear Drug market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Diagnostic Nuclear Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Diagnostic Nuclear Drug companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Diagnostic Nuclear Drug Market Report

Report Metric Details
Report Name Diagnostic Nuclear Drug Market
Accounted market size in year US$ 5363 million
Forecasted market size in 2031 US$ 8500 million
CAGR 6.9%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Tc-99m
  • F-18
  • Other
Segment by Application
  • Oncology
  • Cardiology
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Cardinal Health, GE Healthcare, Curium Pharma, Jubilant Pharma, Bracco Imaging, Novartis, SIEMENS, China Isotope & Radiation, Dongcheng, Lantheus, Eli Lilly
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Diagnostic Nuclear Drug company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Diagnostic Nuclear Drug Market growing?

Ans: The Diagnostic Nuclear Drug Market witnessing a CAGR of 6.9% during the forecast period 2025-2031.

What is the Diagnostic Nuclear Drug Market size in 2031?

Ans: The Diagnostic Nuclear Drug Market size in 2031 will be US$ 8500 million.

Who are the main players in the Diagnostic Nuclear Drug Market report?

Ans: The main players in the Diagnostic Nuclear Drug Market are Cardinal Health, GE Healthcare, Curium Pharma, Jubilant Pharma, Bracco Imaging, Novartis, SIEMENS, China Isotope & Radiation, Dongcheng, Lantheus, Eli Lilly

What are the Application segmentation covered in the Diagnostic Nuclear Drug Market report?

Ans: The Applications covered in the Diagnostic Nuclear Drug Market report are Oncology, Cardiology, Other

What are the Type segmentation covered in the Diagnostic Nuclear Drug Market report?

Ans: The Types covered in the Diagnostic Nuclear Drug Market report are Tc-99m, F-18, Other

Recommended Reports

Radiopharmaceuticals & Isotopes

Diagnostic Imaging Equipment

Nuclear Medicine Therapies

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Diagnostic Nuclear Drug Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Tc-99m
1.2.3 F-18
1.2.4 Other
1.3 Market by Application
1.3.1 Global Diagnostic Nuclear Drug Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Oncology
1.3.3 Cardiology
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Diagnostic Nuclear Drug Market Perspective (2020-2031)
2.2 Global Diagnostic Nuclear Drug Growth Trends by Region
2.2.1 Global Diagnostic Nuclear Drug Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Diagnostic Nuclear Drug Historic Market Size by Region (2020-2025)
2.2.3 Diagnostic Nuclear Drug Forecasted Market Size by Region (2026-2031)
2.3 Diagnostic Nuclear Drug Market Dynamics
2.3.1 Diagnostic Nuclear Drug Industry Trends
2.3.2 Diagnostic Nuclear Drug Market Drivers
2.3.3 Diagnostic Nuclear Drug Market Challenges
2.3.4 Diagnostic Nuclear Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Diagnostic Nuclear Drug Players by Revenue
3.1.1 Global Top Diagnostic Nuclear Drug Players by Revenue (2020-2025)
3.1.2 Global Diagnostic Nuclear Drug Revenue Market Share by Players (2020-2025)
3.2 Global Diagnostic Nuclear Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Diagnostic Nuclear Drug Revenue
3.4 Global Diagnostic Nuclear Drug Market Concentration Ratio
3.4.1 Global Diagnostic Nuclear Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Diagnostic Nuclear Drug Revenue in 2024
3.5 Global Key Players of Diagnostic Nuclear Drug Head office and Area Served
3.6 Global Key Players of Diagnostic Nuclear Drug, Product and Application
3.7 Global Key Players of Diagnostic Nuclear Drug, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Diagnostic Nuclear Drug Breakdown Data by Type
4.1 Global Diagnostic Nuclear Drug Historic Market Size by Type (2020-2025)
4.2 Global Diagnostic Nuclear Drug Forecasted Market Size by Type (2026-2031)
5 Diagnostic Nuclear Drug Breakdown Data by Application
5.1 Global Diagnostic Nuclear Drug Historic Market Size by Application (2020-2025)
5.2 Global Diagnostic Nuclear Drug Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Diagnostic Nuclear Drug Market Size (2020-2031)
6.2 North America Diagnostic Nuclear Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Diagnostic Nuclear Drug Market Size by Country (2020-2025)
6.4 North America Diagnostic Nuclear Drug Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Diagnostic Nuclear Drug Market Size (2020-2031)
7.2 Europe Diagnostic Nuclear Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Diagnostic Nuclear Drug Market Size by Country (2020-2025)
7.4 Europe Diagnostic Nuclear Drug Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Diagnostic Nuclear Drug Market Size (2020-2031)
8.2 Asia-Pacific Diagnostic Nuclear Drug Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Diagnostic Nuclear Drug Market Size by Region (2020-2025)
8.4 Asia-Pacific Diagnostic Nuclear Drug Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Diagnostic Nuclear Drug Market Size (2020-2031)
9.2 Latin America Diagnostic Nuclear Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Diagnostic Nuclear Drug Market Size by Country (2020-2025)
9.4 Latin America Diagnostic Nuclear Drug Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Diagnostic Nuclear Drug Market Size (2020-2031)
10.2 Middle East & Africa Diagnostic Nuclear Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Diagnostic Nuclear Drug Market Size by Country (2020-2025)
10.4 Middle East & Africa Diagnostic Nuclear Drug Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Cardinal Health
11.1.1 Cardinal Health Company Details
11.1.2 Cardinal Health Business Overview
11.1.3 Cardinal Health Diagnostic Nuclear Drug Introduction
11.1.4 Cardinal Health Revenue in Diagnostic Nuclear Drug Business (2020-2025)
11.1.5 Cardinal Health Recent Development
11.2 GE Healthcare
11.2.1 GE Healthcare Company Details
11.2.2 GE Healthcare Business Overview
11.2.3 GE Healthcare Diagnostic Nuclear Drug Introduction
11.2.4 GE Healthcare Revenue in Diagnostic Nuclear Drug Business (2020-2025)
11.2.5 GE Healthcare Recent Development
11.3 Curium Pharma
11.3.1 Curium Pharma Company Details
11.3.2 Curium Pharma Business Overview
11.3.3 Curium Pharma Diagnostic Nuclear Drug Introduction
11.3.4 Curium Pharma Revenue in Diagnostic Nuclear Drug Business (2020-2025)
11.3.5 Curium Pharma Recent Development
11.4 Jubilant Pharma
11.4.1 Jubilant Pharma Company Details
11.4.2 Jubilant Pharma Business Overview
11.4.3 Jubilant Pharma Diagnostic Nuclear Drug Introduction
11.4.4 Jubilant Pharma Revenue in Diagnostic Nuclear Drug Business (2020-2025)
11.4.5 Jubilant Pharma Recent Development
11.5 Bracco Imaging
11.5.1 Bracco Imaging Company Details
11.5.2 Bracco Imaging Business Overview
11.5.3 Bracco Imaging Diagnostic Nuclear Drug Introduction
11.5.4 Bracco Imaging Revenue in Diagnostic Nuclear Drug Business (2020-2025)
11.5.5 Bracco Imaging Recent Development
11.6 Novartis
11.6.1 Novartis Company Details
11.6.2 Novartis Business Overview
11.6.3 Novartis Diagnostic Nuclear Drug Introduction
11.6.4 Novartis Revenue in Diagnostic Nuclear Drug Business (2020-2025)
11.6.5 Novartis Recent Development
11.7 SIEMENS
11.7.1 SIEMENS Company Details
11.7.2 SIEMENS Business Overview
11.7.3 SIEMENS Diagnostic Nuclear Drug Introduction
11.7.4 SIEMENS Revenue in Diagnostic Nuclear Drug Business (2020-2025)
11.7.5 SIEMENS Recent Development
11.8 China Isotope & Radiation
11.8.1 China Isotope & Radiation Company Details
11.8.2 China Isotope & Radiation Business Overview
11.8.3 China Isotope & Radiation Diagnostic Nuclear Drug Introduction
11.8.4 China Isotope & Radiation Revenue in Diagnostic Nuclear Drug Business (2020-2025)
11.8.5 China Isotope & Radiation Recent Development
11.9 Dongcheng
11.9.1 Dongcheng Company Details
11.9.2 Dongcheng Business Overview
11.9.3 Dongcheng Diagnostic Nuclear Drug Introduction
11.9.4 Dongcheng Revenue in Diagnostic Nuclear Drug Business (2020-2025)
11.9.5 Dongcheng Recent Development
11.10 Lantheus
11.10.1 Lantheus Company Details
11.10.2 Lantheus Business Overview
11.10.3 Lantheus Diagnostic Nuclear Drug Introduction
11.10.4 Lantheus Revenue in Diagnostic Nuclear Drug Business (2020-2025)
11.10.5 Lantheus Recent Development
11.11 Eli Lilly
11.11.1 Eli Lilly Company Details
11.11.2 Eli Lilly Business Overview
11.11.3 Eli Lilly Diagnostic Nuclear Drug Introduction
11.11.4 Eli Lilly Revenue in Diagnostic Nuclear Drug Business (2020-2025)
11.11.5 Eli Lilly Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Bracco Imaging
Lantheus
GE Healthcare
China Isotope & Radiation
Jubilant Pharma
Eli Lilly
Novartis
Siemens AG
Dongcheng
Cardinal Health
Curium Pharma
List of Tables
 Table 1. Global Diagnostic Nuclear Drug Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Tc-99m
 Table 3. Key Players of F-18
 Table 4. Key Players of Other
 Table 5. Global Diagnostic Nuclear Drug Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Diagnostic Nuclear Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Diagnostic Nuclear Drug Market Size by Region (2020-2025) & (US$ Million)
 Table 8. Global Diagnostic Nuclear Drug Market Share by Region (2020-2025)
 Table 9. Global Diagnostic Nuclear Drug Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 10. Global Diagnostic Nuclear Drug Market Share by Region (2026-2031)
 Table 11. Diagnostic Nuclear Drug Market Trends
 Table 12. Diagnostic Nuclear Drug Market Drivers
 Table 13. Diagnostic Nuclear Drug Market Challenges
 Table 14. Diagnostic Nuclear Drug Market Restraints
 Table 15. Global Diagnostic Nuclear Drug Revenue by Players (2020-2025) & (US$ Million)
 Table 16. Global Diagnostic Nuclear Drug Market Share by Players (2020-2025)
 Table 17. Global Top Diagnostic Nuclear Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diagnostic Nuclear Drug as of 2024)
 Table 18. Ranking of Global Top Diagnostic Nuclear Drug Companies by Revenue (US$ Million) in 2024
 Table 19. Global 5 Largest Players Market Share by Diagnostic Nuclear Drug Revenue (CR5 and HHI) & (2020-2025)
 Table 20. Global Key Players of Diagnostic Nuclear Drug, Headquarters and Area Served
 Table 21. Global Key Players of Diagnostic Nuclear Drug, Product and Application
 Table 22. Global Key Players of Diagnostic Nuclear Drug, Date of Enter into This Industry
 Table 23. Mergers & Acquisitions, Expansion Plans
 Table 24. Global Diagnostic Nuclear Drug Market Size by Type (2020-2025) & (US$ Million)
 Table 25. Global Diagnostic Nuclear Drug Revenue Market Share by Type (2020-2025)
 Table 26. Global Diagnostic Nuclear Drug Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 27. Global Diagnostic Nuclear Drug Revenue Market Share by Type (2026-2031)
 Table 28. Global Diagnostic Nuclear Drug Market Size by Application (2020-2025) & (US$ Million)
 Table 29. Global Diagnostic Nuclear Drug Revenue Market Share by Application (2020-2025)
 Table 30. Global Diagnostic Nuclear Drug Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 31. Global Diagnostic Nuclear Drug Revenue Market Share by Application (2026-2031)
 Table 32. North America Diagnostic Nuclear Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 33. North America Diagnostic Nuclear Drug Market Size by Country (2020-2025) & (US$ Million)
 Table 34. North America Diagnostic Nuclear Drug Market Size by Country (2026-2031) & (US$ Million)
 Table 35. Europe Diagnostic Nuclear Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 36. Europe Diagnostic Nuclear Drug Market Size by Country (2020-2025) & (US$ Million)
 Table 37. Europe Diagnostic Nuclear Drug Market Size by Country (2026-2031) & (US$ Million)
 Table 38. Asia-Pacific Diagnostic Nuclear Drug Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 39. Asia-Pacific Diagnostic Nuclear Drug Market Size by Region (2020-2025) & (US$ Million)
 Table 40. Asia-Pacific Diagnostic Nuclear Drug Market Size by Region (2026-2031) & (US$ Million)
 Table 41. Latin America Diagnostic Nuclear Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 42. Latin America Diagnostic Nuclear Drug Market Size by Country (2020-2025) & (US$ Million)
 Table 43. Latin America Diagnostic Nuclear Drug Market Size by Country (2026-2031) & (US$ Million)
 Table 44. Middle East & Africa Diagnostic Nuclear Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 45. Middle East & Africa Diagnostic Nuclear Drug Market Size by Country (2020-2025) & (US$ Million)
 Table 46. Middle East & Africa Diagnostic Nuclear Drug Market Size by Country (2026-2031) & (US$ Million)
 Table 47. Cardinal Health Company Details
 Table 48. Cardinal Health Business Overview
 Table 49. Cardinal Health Diagnostic Nuclear Drug Product
 Table 50. Cardinal Health Revenue in Diagnostic Nuclear Drug Business (2020-2025) & (US$ Million)
 Table 51. Cardinal Health Recent Development
 Table 52. GE Healthcare Company Details
 Table 53. GE Healthcare Business Overview
 Table 54. GE Healthcare Diagnostic Nuclear Drug Product
 Table 55. GE Healthcare Revenue in Diagnostic Nuclear Drug Business (2020-2025) & (US$ Million)
 Table 56. GE Healthcare Recent Development
 Table 57. Curium Pharma Company Details
 Table 58. Curium Pharma Business Overview
 Table 59. Curium Pharma Diagnostic Nuclear Drug Product
 Table 60. Curium Pharma Revenue in Diagnostic Nuclear Drug Business (2020-2025) & (US$ Million)
 Table 61. Curium Pharma Recent Development
 Table 62. Jubilant Pharma Company Details
 Table 63. Jubilant Pharma Business Overview
 Table 64. Jubilant Pharma Diagnostic Nuclear Drug Product
 Table 65. Jubilant Pharma Revenue in Diagnostic Nuclear Drug Business (2020-2025) & (US$ Million)
 Table 66. Jubilant Pharma Recent Development
 Table 67. Bracco Imaging Company Details
 Table 68. Bracco Imaging Business Overview
 Table 69. Bracco Imaging Diagnostic Nuclear Drug Product
 Table 70. Bracco Imaging Revenue in Diagnostic Nuclear Drug Business (2020-2025) & (US$ Million)
 Table 71. Bracco Imaging Recent Development
 Table 72. Novartis Company Details
 Table 73. Novartis Business Overview
 Table 74. Novartis Diagnostic Nuclear Drug Product
 Table 75. Novartis Revenue in Diagnostic Nuclear Drug Business (2020-2025) & (US$ Million)
 Table 76. Novartis Recent Development
 Table 77. SIEMENS Company Details
 Table 78. SIEMENS Business Overview
 Table 79. SIEMENS Diagnostic Nuclear Drug Product
 Table 80. SIEMENS Revenue in Diagnostic Nuclear Drug Business (2020-2025) & (US$ Million)
 Table 81. SIEMENS Recent Development
 Table 82. China Isotope & Radiation Company Details
 Table 83. China Isotope & Radiation Business Overview
 Table 84. China Isotope & Radiation Diagnostic Nuclear Drug Product
 Table 85. China Isotope & Radiation Revenue in Diagnostic Nuclear Drug Business (2020-2025) & (US$ Million)
 Table 86. China Isotope & Radiation Recent Development
 Table 87. Dongcheng Company Details
 Table 88. Dongcheng Business Overview
 Table 89. Dongcheng Diagnostic Nuclear Drug Product
 Table 90. Dongcheng Revenue in Diagnostic Nuclear Drug Business (2020-2025) & (US$ Million)
 Table 91. Dongcheng Recent Development
 Table 92. Lantheus Company Details
 Table 93. Lantheus Business Overview
 Table 94. Lantheus Diagnostic Nuclear Drug Product
 Table 95. Lantheus Revenue in Diagnostic Nuclear Drug Business (2020-2025) & (US$ Million)
 Table 96. Lantheus Recent Development
 Table 97. Eli Lilly Company Details
 Table 98. Eli Lilly Business Overview
 Table 99. Eli Lilly Diagnostic Nuclear Drug Product
 Table 100. Eli Lilly Revenue in Diagnostic Nuclear Drug Business (2020-2025) & (US$ Million)
 Table 101. Eli Lilly Recent Development
 Table 102. Research Programs/Design for This Report
 Table 103. Key Data Information from Secondary Sources
 Table 104. Key Data Information from Primary Sources
 Table 105. Authors List of This Report


List of Figures
 Figure 1. Diagnostic Nuclear Drug Picture
 Figure 2. Global Diagnostic Nuclear Drug Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Diagnostic Nuclear Drug Market Share by Type: 2024 VS 2031
 Figure 4. Tc-99m Features
 Figure 5. F-18 Features
 Figure 6. Other Features
 Figure 7. Global Diagnostic Nuclear Drug Market Size by Application (2020-2031) & (US$ Million)
 Figure 8. Global Diagnostic Nuclear Drug Market Share by Application: 2024 VS 2031
 Figure 9. Oncology Case Studies
 Figure 10. Cardiology Case Studies
 Figure 11. Other Case Studies
 Figure 12. Diagnostic Nuclear Drug Report Years Considered
 Figure 13. Global Diagnostic Nuclear Drug Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 14. Global Diagnostic Nuclear Drug Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Diagnostic Nuclear Drug Market Share by Region: 2024 VS 2031
 Figure 16. Global Diagnostic Nuclear Drug Market Share by Players in 2024
 Figure 17. Global Top Diagnostic Nuclear Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diagnostic Nuclear Drug as of 2024)
 Figure 18. The Top 10 and 5 Players Market Share by Diagnostic Nuclear Drug Revenue in 2024
 Figure 19. North America Diagnostic Nuclear Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 20. North America Diagnostic Nuclear Drug Market Share by Country (2020-2031)
 Figure 21. United States Diagnostic Nuclear Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Canada Diagnostic Nuclear Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe Diagnostic Nuclear Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Diagnostic Nuclear Drug Market Share by Country (2020-2031)
 Figure 25. Germany Diagnostic Nuclear Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. France Diagnostic Nuclear Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. U.K. Diagnostic Nuclear Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Italy Diagnostic Nuclear Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Russia Diagnostic Nuclear Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Nordic Countries Diagnostic Nuclear Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific Diagnostic Nuclear Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Diagnostic Nuclear Drug Market Share by Region (2020-2031)
 Figure 33. China Diagnostic Nuclear Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Japan Diagnostic Nuclear Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. South Korea Diagnostic Nuclear Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Southeast Asia Diagnostic Nuclear Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. India Diagnostic Nuclear Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Australia Diagnostic Nuclear Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America Diagnostic Nuclear Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Diagnostic Nuclear Drug Market Share by Country (2020-2031)
 Figure 41. Mexico Diagnostic Nuclear Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Brazil Diagnostic Nuclear Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa Diagnostic Nuclear Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Diagnostic Nuclear Drug Market Share by Country (2020-2031)
 Figure 45. Turkey Diagnostic Nuclear Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Saudi Arabia Diagnostic Nuclear Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. UAE Diagnostic Nuclear Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Cardinal Health Revenue Growth Rate in Diagnostic Nuclear Drug Business (2020-2025)
 Figure 49. GE Healthcare Revenue Growth Rate in Diagnostic Nuclear Drug Business (2020-2025)
 Figure 50. Curium Pharma Revenue Growth Rate in Diagnostic Nuclear Drug Business (2020-2025)
 Figure 51. Jubilant Pharma Revenue Growth Rate in Diagnostic Nuclear Drug Business (2020-2025)
 Figure 52. Bracco Imaging Revenue Growth Rate in Diagnostic Nuclear Drug Business (2020-2025)
 Figure 53. Novartis Revenue Growth Rate in Diagnostic Nuclear Drug Business (2020-2025)
 Figure 54. SIEMENS Revenue Growth Rate in Diagnostic Nuclear Drug Business (2020-2025)
 Figure 55. China Isotope & Radiation Revenue Growth Rate in Diagnostic Nuclear Drug Business (2020-2025)
 Figure 56. Dongcheng Revenue Growth Rate in Diagnostic Nuclear Drug Business (2020-2025)
 Figure 57. Lantheus Revenue Growth Rate in Diagnostic Nuclear Drug Business (2020-2025)
 Figure 58. Eli Lilly Revenue Growth Rate in Diagnostic Nuclear Drug Business (2020-2025)
 Figure 59. Bottom-up and Top-down Approaches for This Report
 Figure 60. Data Triangulation
 Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Novocure

SIMILAR REPORTS

Global Diagnostic Nuclear Medicines Market Insights Forecast to 2030
Global Diagnostic Radioisotopes Market Insights Forecast to 2030
Global Diagnostic Radiopharmaceuticals Market Research Report 2024
Global Radiopharmaceuticals in Nuclear Medicine Market Research Report 2025
Global Radiopharmaceutical Therapy Market Research Report 2025
Global Radiopharmaceuticals for Diagnosis Market Research Report 2024
Global Nuclear Medicine Radiopharmaceuticals Market Research Report 2024
Global Radioisotopes in Medicine Market Research Report 2025
Global Nuclear Medicine Market Research Report 2025
Global Nuclear Medicine Radioisotopes Market Insights Forecast to 2030
Nuclear Drug for Therapeutic Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Nuclear Medicine Equipment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Therapeutic Nuclear Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Medical Radioisotopes Market Research Report 2025
Global SPECT and PET Radiopharmaceuticals Market Research Report 2024
Global Radioactive Therapeutic Drugs Market Research Report 2024
Nuclear Medicine Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Radiopharmaceutical Market Research Report 2025
Nuclear Medicine Isotopes Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Therapeutic Radioisotopes Market Insights Forecast to 2030

RELATED REPORTS

Global GLP-1 Targeted Peptide Weight Loss Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19A18322
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Stimulant-Free Fat Burners Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3E3525
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Test Boosters Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35T3049
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Salsalate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33Y1801
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions